Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals

Area of Science:

• Biochemistry
• Biophysics
• Materials Science

Background:

• Matrix Gla Protein (MGP) deficiency in mice leads to severe arterial calcification and early mortality.
• MGP is hypothesized to prevent arterial calcification by interacting with hydroxyapatite (HA) crystals.

Purpose of the Study:

• To investigate the mechanism by which MGP inhibits hydroxyapatite crystal growth.
• To determine the role of specific MGP post-translational modifications (γ-carboxylation and serine phosphorylation) in HA crystal interaction.

Main Methods:

• Synthesis of human MGP peptides covering its entire sequence.
• Assessing HA crystal growth inhibition using constant-composition autotitration assays.
• Analyzing peptide-HA interactions via atomistic molecular dynamics (MD) simulations on HA crystal faces.

Main Results:

• MGP peptides YGlapS and SK-Gla strongly inhibited HA growth and rapidly adsorbed to HA crystals.
• QR-Gla showed moderate inhibition, while non-modified peptides had minimal effect.
• Gla and phosphoserine residues were crucial for the adsorption and inhibitory activities of specific MGP peptides.

Conclusions:

• MGP directly interacts with hydroxyapatite crystals, preventing arterial calcification.
• The findings highlight the importance of MGP’s post-translational modifications for its anti-calcification function.
• Molecular dynamics simulations effectively predict the impact of MGP peptides on crystal formation.